I understand CXS doing early due diligence on CYT as CXS exhibits greater conficence of upcoming successful IND approval in US for omacetaxine. Clearly CXS looking to access additional local well advanced oncology drug development programs and exhibiting confidence its own management to repeat what others have struggled to do themselves in this country. Will be watching closely.
- Forums
- ASX - By Stock
- acquisition
I understand CXS doing early due diligence on CYT as CXS...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CYT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online